Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Hydroxocobalamin - Generic Drug Details

« Back to Dashboard
Hydroxocobalamin is the generic ingredient in four branded drugs marketed by Abraxis Pharm, Watson Labs, Bel Mar, Serb Sa, and Merck, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has twelve patent family members in nine countries.

There are four drug master file entries for hydroxocobalamin. Three suppliers are listed for this compound.

Summary for Generic Name: hydroxocobalamin

Drug Master File Entries: see list4
Suppliers / Packaging: see list3
Drug Prices:see low prices

Pharmacology for Ingredient: hydroxocobalamin

Drug ClassAntidote

Clinical Trials for: hydroxocobalamin

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar
INJECTABLE;INJECTION084629-001Approved Prior to Jan 1, 1982DISCNNo
Watson Labs
INJECTABLE;INJECTION085998-001Approved Prior to Jan 1, 1982RXYes
Serb Sa
INJECTABLE;INJECTION022041-002Dec 15, 2006DISCNNo5,834,448Nov 14, 2016Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: hydroxocobalamin

Country Document Number Estimated Expiration
Germany69619767► subscribe
Japan3699223► subscribe
Norway964825► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.